Open Health names new director of rare disease
12 March 2018 -

Open Health, a healthcare communications and market access group, has named Gavin Jones as its new director of rare disease, it was reported on Friday.

Jones will work in close collaboration with all of the Open Health agencies, driving their present and future partnerships with customers working in rare diseases. Joining the agency with twenty years' biopharmaceutical industry experience, Jones' expertise lies in market access, therapy launch and patient centric services.

Sandy Roydon, Open Health's chief executive officer, said, 'We are delighted that Gavin has joined us to further strengthen our partnerships with customers in rare disease. Creating a unique role within our field of expertise will enable us to offer a market leading position in supporting our customers work towards greater access and uptake of their innovative and much needed treatments.'